Login to Your Account

CEO: 'Firing on All Cylinders'

Alkermes Boasts Commercial, Portfolio Growth in Solid 1Q13

By Jennifer Boggs
Managing Editor

Monday, July 30, 2012

Alkermes plc posted its most impressive quarter so far since last fall's acquisition of Elan Corp. plc's drug delivery unit and relocation of its headquarters to Dublin, Ireland, reporting total revenues of $152.2 million, a 146 percent jump over the same three-month period in 2011.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription